Jushi Holdings Inc. (OTCMKTS:JUSHF – Free Report) – Investment analysts at Seaport Res Ptn lowered their FY2024 earnings estimates for shares of Jushi in a research note issued on Monday, November 25th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings of ($0.17) per share for the year, down from their prior estimate of ($0.11). The consensus estimate for Jushi’s current full-year earnings is ($0.21) per share. Seaport Res Ptn also issued estimates for Jushi’s Q4 2024 earnings at ($0.05) EPS, Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.14) EPS.
Jushi (OTCMKTS:JUSHF – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.04). Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%. The firm had revenue of $61.61 million during the quarter, compared to analysts’ expectations of $65.53 million.
Read Our Latest Report on JUSHF
Jushi Price Performance
Shares of OTCMKTS JUSHF opened at $0.35 on Wednesday. Jushi has a 1 year low of $0.22 and a 1 year high of $1.09. The company’s 50-day moving average is $0.46 and its 200 day moving average is $0.54. The stock has a market capitalization of $68.28 million, a P/E ratio of -1.29 and a beta of -0.86.
Jushi Company Profile
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Featured Stories
- Five stocks we like better than Jushi
- The Most Important Warren Buffett Stock for Investors: His Own
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Conference Calls and Individual Investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Retail Stocks Investing, Explained
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.
